Atlas Trials

DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS

Clinical trial NCT07571291 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07571291
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Pulmonary Fibrosis
Start date
2026-01-01
Primary completion
2026-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.